SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differenti... SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. Show more
STAMFORD, Conn., Jan. 30, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...
– Achieved $61.5 million and $172.0 million in preliminary fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively – – Ended 2024 with approximately $462...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.78 | 4.98320268757 | 35.72 | 38.6825 | 35.36 | 1179370 | 36.17819492 | CS |
4 | 1.39 | 3.84934921074 | 36.11 | 45.65 | 31.955 | 1855735 | 37.55728035 | CS |
12 | 4.35 | 13.1221719457 | 33.15 | 45.65 | 29.53 | 1448029 | 37.39941542 | CS |
26 | 0.48 | 1.29659643436 | 37.02 | 45.65 | 28.21 | 1143933 | 36.02948141 | CS |
52 | -6.2 | -14.1876430206 | 43.7 | 53.92 | 28.21 | 1064095 | 40.02253059 | CS |
156 | -15.15 | -28.7749287749 | 52.65 | 65.92 | 13.6 | 897148 | 33.56982764 | CS |
260 | 3.67 | 10.8483594443 | 33.83 | 96.48 | 13.6 | 647873 | 38.65662421 | CS |
Symbole | Prix | Vol. |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 731,1M |
NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,5M |
RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 341,8M |
CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 237,15M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,44M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales